Prelude Capital Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,415
Closed -$1.45M 1242
2023
Q3
$1.45M Buy
+6,415
New +$1.45M 0.09% 201
2021
Q3
Sell
-33,635
Closed -$6.03M 1729
2021
Q2
$6.03M Buy
33,635
+11,160
+50% +$2M 0.18% 49
2021
Q1
$3.76M Buy
22,475
+615
+3% +$103K 0.1% 72
2020
Q4
$3.32M Buy
21,860
+20,998
+2,436% +$3.19M 0.08% 64
2020
Q3
$87K Sell
862
-3,318
-79% -$335K ﹤0.01% 728
2020
Q2
$506K Buy
+4,180
New +$506K 0.03% 283
2019
Q3
Sell
-222
Closed -$17K 1590
2019
Q2
$17K Buy
+222
New +$17K ﹤0.01% 950
2017
Q4
Sell
-2,406
Closed -$282K 1598
2017
Q3
$282K Buy
+2,406
New +$282K 0.03% 481
2017
Q1
Sell
-2,888
Closed -$414K 1736
2016
Q4
$414K Buy
+2,888
New +$414K 0.05% 322
2016
Q3
Sell
-1,981
Closed -$210K 1759
2016
Q2
$210K Sell
1,981
-4,504
-69% -$477K 0.03% 442
2016
Q1
$723K Sell
6,485
-708
-10% -$78.9K 0.1% 191
2015
Q4
$1.13M Buy
7,193
+4,345
+153% +$680K 0.17% 125
2015
Q3
$374K Sell
2,848
-559
-16% -$73.4K 0.05% 314
2015
Q2
$593K Sell
3,407
-640
-16% -$111K 0.08% 255
2015
Q1
$698K Sell
4,047
-334
-8% -$57.6K 0.1% 245
2014
Q4
$567K Sell
4,381
-1,927
-31% -$249K 0.08% 250
2014
Q3
$812K Buy
6,308
+674
+12% +$86.8K 0.11% 200
2014
Q2
$499K Sell
5,634
-2,098
-27% -$186K 0.07% 333
2014
Q1
$727K Buy
7,732
+1,856
+32% +$175K 0.1% 241
2013
Q4
$664K Buy
5,876
+1,780
+43% +$201K 0.11% 231
2013
Q3
$323K Sell
4,096
-8,257
-67% -$651K 0.05% 343
2013
Q2
$813K Buy
+12,353
New +$813K 0.17% 115